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Abstract—While developed countries constantly pioneer new 
medical technologies, developing countries have been plighted 
with a lack of medical devices, resulting in poor health, poverty, 
and social inequality.  Much of the medical equipment that these 
countries do have is broken, unusable due to a lack of electricity 
and infrastructure, or inappropriate for local needs.  In 2000, the 
Global Forum for Health Research coined the term “10/90 Gap” 
to describe the fact that only 10% of health research funds are 
spent on the problems of 90% of the world’s population.  If the 
developing world is to acquire useful medical technologies, it 
must come from within, as the developed world has shown 
minimal interest in pursuing technologies for markets where the 
financial return is only nominal.  If engineers in developed 
countries put their energy and resources into building the 
capacity of their counterparts in developing countries, they will 
be able to maximize their impact on the most relevant issues in 
global health.  In order to succeed in their work abroad, 
biomedical engineers from developed countries must transition 
from being providers of solutions, to enablers of local innovation, 
thus contributing directly to both education and implementation.  
This paper addresses current challenges and appropriate 
solutions to tackle the lack of biomedical engineering education 
and innovation in developing countries. 
Keywords—appropriate technology; biomedical engineering 
(BME); biomedical engineering education; cross-cultural 
communication; international collaboration; patents; problem-
solving; technology transfer; volunteer activities 
I.  INTRODUCTION 
As the health care debate in the developed world has 
focused on domestic costs and [national] universal access, the 
spotlight has drifted even further away from the developing 
world and its need for greater resources for improved health.  
The luxury of debating universal access to health care has not 
yet hit most developing countries, as there is a glaring absence 
of the technology and infrastructure required to provide their 
entire populations with improved health.  While developed 
countries delve into the realms of nanotechnology and 
decoding the human genome, developing countries are 
struggling to give x-rays—the conventional film kind—to those 
who need them, to provide the sick with drugs that are 
guaranteed not to be counterfeit, and to accurately diagnose 
common ailments such as pneumonia, malaria, and HIV in the 
field.  Despite all the research and progress that has gone into 
medical technologies in developed countries, developing 
countries, which comprise a majority of the world‘s population, 
have minimal, if any, access to many of these innovations [1]. 
This concern over the lack of technology transfer to the 
developing world is not new; the reasons for it have been 
thoroughly documented in many papers.  Nearly every paper 
that has covered this problem has also proposed solutions to 
overcoming it.  Most of these solutions involve creating 
national-level management systems to coordinate and regulate 
foreign donations, open-sourcing technology to work around 
copyright laws, and massively subsidizing devices for the 
developing world with profits from the developed world.  
However, relatively few papers in the literature have touched 
on the need for robust systems of engineering and innovation 
within developing countries.  Foreign technology can only take 
a resource-limited country so far; in order to be truly 
sustainable, innovation must be endogenous—it must come 
from within. 
II. BACKGROUND 
In developing countries, over 95% of the medical 
equipment in public hospitals is imported, with virtually no 
local production [2].  Moreover, most of the equipment is 
inappropriate for local needs and unable to be sustained with 
the lack of local infrastructure.  Referring to a study of 
donations to Columbia from 1974-1979, Pena-Mohr, of the Pan 
American Health Organization, points out that five years after 
donation, ―96% of foreign-donated equipment was not 
working.‖  That same study revealed that 36% of the donations 
did not work upon arrival due to lack of training, manuals, or 
accessories [2, pp. 571]. 
In sub-Saharan Africa alone, 70% of existing equipment is 
not used, while ―at least half of all medical equipment in the 
developing world is unusable‖ [3, pp. 54].  What makes these 
statistics even more appalling is the fact that US$70-160 billion 
per year are spent on health research and development (R&D) 
worldwide [4], [5].  These data are captured in the aptly named 
―10/90 Gap,‖ coined by the Global Forum for Health Research, 
to describe the 10% of health research funds that are spent on 
the problems of 90% of the world‘s population [4], [6]. 
The lack of working devices in developing countries is due 
to a multi-faceted, systemic failure.  While the genesis of this 
problem has been outlined ad nauseam, it is necessary to 
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highlight the main aspects that have created the present 
situation. 
A. Developed World Devices are too Expensive 
Developing countries often lack the funds to fully assess all 
their needs, let alone develop technologies to address their 
needs [1], [7].  The US$10-20 million cost of device R&D is 
often far out of reach of developing country budgets.  
Moreover, the costs of purchasing foreign devices can be 
prohibitive for small, publicly funded clinics and hospitals.  
Device manufacturers know that they will never recoup R&D 
costs in developing countries, thus they do not even attempt to 
enter the developing world market knowing they will get 
minimal return, if any, on their investment [8].  Similarly, due 
to companies determining their products by demand and 
market size—the market of those able and willing to pay—and 
not public health need [1], much R&D has gone into profitable 
areas such as erectile dysfunction and cosmetic surgery while 
leaving neglected diseases such as Chikungunya and Chagas 
with little attention. 
B. Lack of Supporting Technology/Infrastructure 
Electricity: While the paucity of medical devices is 
significant, one of the main obstacles to successful use of 
appropriated devices is the lack of supporting technologies and 
infrastructure.  Unreliable electricity, including spikes and 
brownouts, makes it difficult to store vaccines that need to be 
refrigerated and necessitates expensive back-up generators and 
the fuel to run them.  Additionally, donated units may be 
incompatible with local power supplies of different voltages 
and frequencies than their countries of origin [3].  As Malkin 
and Anand explained, ―[The phototherapy device] would only 
be useful for babies born when the electricity was on, and then 
only those that required treatment lasting less than the time 
until the electricity was off again‖ [8, pp. 37]. 
Human resources: Recipients often lack the expertise and 
training to maintain, troubleshoot, and repair foreign devices 
[3], [8].  This issue is particularly true for low-income countries 
where skilled labor is scarce, brain drain is common, and 
appropriate jobs for skilled engineers and technicians are hard 
to find and influenced by political, tribal, and regional 
affiliations and nepotism.  Many devices designed in developed 
countries require specialized technicians and tools and are not 
built with the intent to be fixed easily by general mechanics 
with only basic tools [8].  Unfortunately, curriculum in 
engineering and technical colleges is dated and the graduates 
are not able to fill the void needed in the society.  
Parts availability: High-tech devices often require 
expensive replacement parts.  Due to the rugged environments 
of most developing countries, the devices fail frequently and 
access to replacement parts is often difficult and expensive [8].  
Lack of financial resources, manufacturing equipment, and 
capacity to fabricate parts is nonexistent.  Lack of quality 
control also affects the quality of the parts available in the 
market.   
Financial burden of donated devices: A donated device 
may cost more to maintain and use than can be afforded, thus 
making the donated device a greater financial burden than help, 
especially if the scarce resources are needed elsewhere.  
C. Devices are Culturally Inappropriate 
The common thinking that ―something is better than 
nothing‖ is incorrect at best, and dangerous at worst, when used 
in regard to health care delivery in developing countries.  The 
fact that resources are scarce makes it imperative that 
technology works well, as there are no resources to correct 
problems or alternatives to treatment.  A recent study by 
Malkin and Anand found that the homemade appearance of 
their prototype phototherapy device elicited concerns of 
dubious quality and possible feelings of inferiority, making 
locals reluctant to use it.  With no alternative treatments 
available, individuals were willing to forgo treatment altogether 
due to their concern over the appearance, and thus, efficacy of 
the device [8]. 
D. Lack of Robustness 
Due to harsh environments (extreme temperatures, 
humidity, dust, etc.) in regions of many developing countries, 
devices that have been designed to operate in the sterile, 
climate-controlled work environments of many western 
medical facilities have very short life spans abroad [1], [8].  
This is particularly true for devices that require biologics (e.g. 
blood, urine, live attenuated vaccines), all of which require 
refrigeration and frequent sterilization.  These devices often fail 
due to the lack of necessary refrigeration and the biologics‘ 
short shelf life.  The lack of capacity to maintain the devices 
further compounds problems due to misuse and neglect. 
III. LACK OF BIOMEDICAL ENGINEERING INNOVATION IN 
THE DEVELOPING WORLD 
There is a clear lack of biomedical engineering (BME) 
education and practice in developing countries.  Of the 9,659 
biotechnology patents reported by the Organization for 
Economic Co-operation and Development (OECD) in 2008, 
4,062 (42%) are from the United States, while only 97 (1%) are 
from India [9].  (See Table I.)  Moreover, of the 194 World 
Health Organization (WHO) member countries, 102 (53%) 
have at least one BME teaching facility contact, 64 (33%) have 
more than one contact, and only 44 (23%) have more than two 
contacts [10].  The regional distribution of BME teaching 
facilities is illustrated in Table II.  This global lack of BME 
teaching institutions makes it clear that there are few cohorts of 
biomedical engineers in the developing world to focus on 
issues in their own countries. 













United States 4,062 42.1 155 26.5 
India 97 1.0 15 2.6 
China 225 2.3 14 2.4 
South Africa 18 0.2 4 0.7 

















21 9 12 43 
European 
Region 
54 37 17 69 
Region of the 
Americas 
35 29 6 83 
South-East 
Asian Region 
11 11 0 100 
Western 
Pacific Region 
27 8 19 30 
Total 194 102 92 53 
A. Incorrect Paradigm of Success 
The common perception among researchers in developed 
countries continues to be that the criteria for successful 
technology are for it to be ―known, effective, and economical‖ 
[2, pp. 568].  However, recent studies by ―Engineering World 
Health‖ argue that this paradigm is not sufficient; explaining, 
―a vaccine for polio has been known, effective, and economical 
for many years, yet polio still plagues the developing world‖ 
[2, pp. 569], [11].  If developing countries are to obtain 
necessary medical technologies, developers worldwide, are 
going to have to understand the complexities of adoption and 
sustained use.  ―Known, effective, and economical‖ is an over-
simplification that will only serve as an impediment in our 
continued work towards improved health.  A lack of resources 
not only implies poor economic and technical capital, but also 
poor human resources with limited education and technical 
knowledge. 
B. Lack of Medical Device Management Systems 
Many developing countries lack governmental management 
and regulatory systems for medical devices [1], [8].  
Preliminary findings of a study by the Diagnostic Imaging and 
Medical Devices Unit of the WHO found that: 
The majority of countries responding to the survey do 
not have a health technology national policy. This 
refers to an official written document approved at 
national level to guide the management of health 
technology related activities such as medical 
equipment management, planning, assessment or 
regulation. [12] 
Of the 196 countries surveyed, 73% reported having a ―unit 
within the Ministry of Health that manages medical devices 
through health technology assessment and management‖ [12]; 
while 65% have ―an authority responsible for implementing 
and enforcing medical device specific product regulations‖ 
[12].  Though these percentages seem relatively high, it is 
important to note that the preliminary findings do not make a 
distinction between developed and developing countries.  Thus, 
assuming that most developed countries have these institutions 
in place, the percentage of developing countries with these 
institutions is significantly lower. 
This lack of medical device oversight has resulted in 
unregulated donations of devices of questionable quality and 
utility.  The same WHO study found that only 42% of countries 
―recommended technical specifications of medical devices to 
support procurement or donations‖ [12].  Only 15% of 
countries adhere to WHO guidelines regarding donations, 26% 
have developed their own national guidelines and 58% have no 
guidelines for donations [12]. 
C. Misguided Funding 
When it comes to medical devices, most developing 
countries do not need the latest, cutting-edge technologies—
they often lack the funds and infrastructure to support such 
products, and have no mechanism to maintain the equipment 
and procure or manufacture replacement parts.  What they need 
are basic, robust devices that are inexpensive and easy to use 
and maintain.  Developing these devices consists of effectively 
retrofitting and stripping down existing technologies to make 
them appropriate to the needs and resources of the region.  This 
process of ―reengineering‖ merits an approach that is grounded 
in a rigorous engineering framework that not only builds 
appropriate technologies that are affordable and culturally 
acceptable but are also able to perform tasks in resource-poor 
environments.  However, most R&D funding—especially the 
grant-based approach—aims at new, high-tech product 
development, not retrofitting existing products, which do not 
result in patents, intellectual property, and groundbreaking 
discoveries [8], [13]. 
IV. MOVING FORWARD – LOCAL BIOMEDICAL 
ENGINEERING 
Many solutions to overcoming the lack of medical devices 
in developing countries have been put forth; these ideas have 
ranged from aggregating markets [8] to increased donation 
regulation and oversight [14].  This paper presents cultivating 
local biomedical engineers as a viable solution.  While the most 
successful initiative is likely to take a systems approach and 
combine many solutions, it is crucial that endogenous BME be 
the keystone of any steps moving forward.  As Dr. Margaret 
Chan, WHO Director-General, stated ―progress in public health 
depends on innovation‖ [14, pp. 34], and who knows the 
problems, available resources, and necessities of developing 
countries better than their residents? 
Greater endogenous BME can overcome numerous 
obstacles currently impeding the adoption of medical devices in 
developing countries.  Because the private sector, especially 
that of developed countries, has shown relatively modest 
interest in investing in the public health of developing countries 
[7], greater local innovation will put the expertise directly in 
the hands of those who are adversely effected by these health 
problems.  Local biomedical engineers will have better 
knowledge of the locally available resources needed to develop 
and maintain technologies, as well as the cultural context in 
which the technology must be adopted.  Moreover, in the 
United States, the Food and Drug Administration (FDA), 
requires that all devices manufactured exclusively for use 
abroad, be able to obtain their approval.  Though the devices do 
not have to obtain the approval, but simply be able to, it is still 
prohibitively expensive to get a device through all the trials and 
regulations in order to comply.  The most obvious way around 
this obstacle is developing and manufacturing devices in other 
countries instead of trying to recoup R&D and testing costs by 
selling at exorbitant prices to developing countries [8].  Finally, 
people support what they create.  Educating and empowering 
local engineers to solve the most pressing issues of their 
communities is the best way to ensure that the technologies will 
be adopted [7].  Local BME education is the most important 
component of a multi-pronged strategy to increase innovation 
and robustness of medical technologies. 
While a significant majority of developing countries have 
engineering programs, they are not tailored to engineering in 
the health sector.  The output of these institutions is engineers 
who have little, if anything, to contribute to the local 
biomedical markets.  Similarly, technician-training programs in 
developing countries have focused largely on the electrical and 
mechanical technical markets with little emphasis on the 
biomedical sector.  Furthermore, lack of integration between 
doctors, hospital managers, ministries of health, and the 
technical education sector has resulted in disjointed and poorly 
managed efforts at the national level.  
In order to foster greater local BME, there are certain 
challenges that must be acknowledged. 
A. Useful Technology is Better than “Cool” Technology 
(Cool and Useful is the Best) 
The western fascination with new, cutting-edge technology 
has led to engineers from developed countries often assuming 
people in developing countries have the same needs and 
desires.  Understanding the social and environmental context 
within which the device will be used is critical to successful 
adoption and continued use; focusing on device utility, rather 
than cutting-edge innovation is what is needed the most [1].  
However, a device that is both useful and ―cool‖ presents the 
greatest opportunity for success. 
B. Technological Versus Social Interventions 
There is a lack of consensus regarding the role of 
technologic interventions as compared to social interventions 
(microfinance, education, etc.) and increased social services 
[2], [6].  Increased endogenous BME incorporates both 
approaches—focusing on increased social capacity to increase 
technologic output. 
V. CRITERIA FOR SUCCESS 
There is no one-size-fits-all method for fostering greater 
endogenous BME.  However, in order for this concept to take 
hold, certain criteria need to be met. 
A. Strong Partnerships and Local Ownership 
Successful interventions require that local institutions and 
companies find partners that have appropriate and useful skills 
as well as resources [3].  While international partnerships are 
appealing due to currency exchanges and access to different 
resources, domestic partnerships can also be utilized to ensure 
successful interventions and initiatives.  As with any 
intervention, there must be local ownership and participation in 
order for there to be success [3].  This is especially important in 
regard to BME for developing countries, as many of the 
problems thus far have been a result of a lack of local 
ownership and voice in global BME [13]. 
B. Greater Access to Research and Literature 
In order for local engineers to maximize their impact, they 
must have greater access to state-of-the-art research and 
literature [13].  Valuable time cannot be lost working with 
outdated and incomplete data.  Though the Internet has greatly 
improved access to literature and research, much still remains 
inaccessible to many institutions in developing countries [13].  
Increasing access to current academic journals for both 
academic institutions with programs such as HealthNet News, 
which features free peer-reviewed literature for health workers 
in low and middles income countries, is paramount [15]. 
C. Device Criteria 
Many institutions have put forth guidelines for medical 
devices for developing countries.  The criteria developed by the 
WHO, World Bank, UNICEF, and UNDP for infectious 
disease diagnostic devices for developing countries, is that all 




 User-friendly – simple to perform in a few steps with 
minimal training 
 Rapid and Robust – enable treatment at the first visit  
 Equipment-free – easily collected non-invasive 
specimens (e.g. urine, saliva) 
 Deliverable – to end-users [16] 
Others have added to this list that the devices be available 
long-term, of adequate and consistent quality [7], and look 
professional [8].  It is vital that engineers take these criteria into 
consideration when developing medical devices.  Because local 
engineers are more aware of material availability, cultural 
appropriateness, and potential for acceptance and continued 
use, they are best equipped to design devices that will be 
adopted in their countries. 
VI. POTENTIAL APPROACHES 
The goal of this paper is not to present a singular way of 
improving the lack of medical devices in developing countries.  
Others have put forth their ideas to confront this issue, all of 
which show potential for success.  However, it is the 
combination of many of these approaches, plus others not listed 
here, which will foster improved global health. 
A. Developing World Academics Add to Leading Research 
Fostering greater endogenous BME is not limited to the 
laboratory; academics from developing countries must add 
their knowledge and experience to the ever-growing 
knowledge-pool of BME research [13].  Garnering support, 
whether financial or otherwise, is always easier for high-profile 
problems such as HIV/AIDS and malaria.  Local academics 
have the ability to raise status of region-specific problems to a 
higher profile; this will help gain the support of regional and 
international partners [7]. 
B. Partner with Foreign Institutions and Companies 
If BME institutions can partner with commercial companies 
they can gain access to greater resources and thus create lower-
cost technologies [7].  Additionally, partnering with BME 
institutions in developed countries will allow for a greater 
exchange of resources and ideas; this would also give the 
developed country schools potential access to field-testing [8].  
The Indo-US Collaboration for Engineering Education 
(IUCEE) runs courses taught by American engineering 
professors for their Indian colleagues to learn new ways of 
teaching engineering [17].  This exchange also allows 
American professors to gain a better understanding of the 
issues facing other populations.  Recently, the U.S. Department 
of Health and Human Services partnered with the U.S. 
President‘s Emergency Plan for AIDS Relief (PEPFAR) to roll 
out the Medical Education Partnership Initiative (MEPI).  This 
initiative awards grants to institutions in Sub-Saharan Africa to 
develop or enhance their medical education programs [18].  A 
similar program for BME programs would be a means of 
strengthening local capacities in this field. 
C. Utilize Volunteer Groups 
Student groups, such as Engineers Without Borders, not 
only give students from developed country institutions an 
opportunity to apply their skills in low-resources areas, but they 
also provide local engineers with access to aspiring engineers 
who have had unfettered access to the latest research and ideas.  
This opportunity has the potential to make a strong impact on 
both parties; the key is for the visiting engineers to teach, not 
give handouts. 
VII. CONCLUSION 
In order to confront the numerous factors that have led to 
the current lack of medical devices and innovative capacity in 
BME in the developing world, a truly systemic approach must 
be taken.  The cornerstone of this approach needs to be 
increasing local capacity for BME, both in terms of education 
and practice of the discipline.  Greater endogenous BME has 
the potential to narrow the medical device chasm between 
developed and developing countries while simultaneously 
building the capacity of local people.  Solving the medical 
device dilemma will result in much-improved public health and 
greater global equity. 
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